Combination of rituximab and low-dose glucocorticoids for idiopathic refractory nephrotic syndrome with MCD/FSGS: a single-center prospective cohort study
Authors
Youqi Li (ORCID: https://orcid.org/0000-0003-3867-5997)
Junbing He (ORCID: https://orcid.org/0000-0002-6916-4770)
Wenwen Jiao
Aikeda Yimamuyushan
Jianbo Li (ORCID: https://orcid.org/0000-0001-7916-0944)
Combination of rituximab and low-dose glucocorticoids for idiopathic refractory nephrotic syndrome with MCD/FSGS: a single-center prospective cohort study
Youqi Li, Junbing He, Wenwen Jiao, Aikeda Yimamuyushan et al.
Citations
4 citations
Journal
Renal Failure
Topics
Renal Diseases and Glomerulopathies
Field-Weighted Citation Impact (FWCI)
1.36
article
Combination of rituximab and low-dose glucocorticoids for idiopathic refractory nephrotic syndrome with MCD/FSGS: a single-center prospective cohort study
Sun Yat-sen University (CN), Fuyang City People's Hospital (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), Huizhou Central People's Hospital (CN)
Funders
National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province